Histoblood group antigens, viruses & asthma excerbation

组织血型抗原、病毒

基本信息

  • 批准号:
    7235400
  • 负责人:
  • 金额:
    $ 49.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2009-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective is to explore the role of histoblood group antigens in virus-induced asthma exacerbations. These antigens (ABH and Lewis) decorate O- and N-linked glycans on mucin and epithelial glycoproteins, respectively. Glycan synthesis involves glycosyltransferases, including fucosyltransferases encoded by FUT genes; glycan degradation involves glycosidases, including fucosidase. "Secretor status" is defined by FUT2 activity in epithelial cells, which forms the H antigen and allows subsequent synthesis and secretion of A, B, and Lewis B antigens. In preliminary data, we found that asthmatic subjects with frequent exacerbations are more likely than non-exacerbators to be secretors, that secretors more frequently report that a cold causes asthma, and that sputum in stable asthma has abnormally high fucosidase activity. This suggests that airway glycans are subjected to 2 competing homoeostatic influences, a) the diversity and activity of glycosyltransferases within cells that synthesize glycans, and b) the diversity and activity of glycosidases that turn over and remodel them in the airway lumen. We hypothesize that secretor positive asthmatic subjects are susceptible to virus-induced asthma exacerbation and that abnormal glycosidase activity in secretions modifies the glycan coat and promotes virus-induced exacerbation. In Aim 1, we propose a case control study to compare secretor status in hospitalized asthmatics and outpatient asthmatics without a history of exacerbation. The relationships between secretor status and FUT gene and histo-blood group antigen expression in airway epithelial cells will also be established. In Aims 2 and 3, we will determine if binding of rhinovirus to airway mucins or to airway epithelial cells is influenced by secretor status or by fucosidase activity. In Aim 4 we will determine if Th2 cytokines influence epithelial cell susceptibility to rhinovirus infection by changing epithelial cell expression of glycolytransferases or glycosidases. These are novel lines of inquiry into the mechanisms of virus-induced asthma exacerbation and may prompt novel treatments.
描述(由申请方提供):目的是探索组织抗原组抗原在病毒诱导的哮喘急性发作中的作用。这些抗原(ABH和刘易斯)分别修饰粘蛋白和上皮糖蛋白上的O-和N-连接聚糖。聚糖合成涉及糖基转移酶,包括由FUT基因编码的岩藻糖基转移酶;聚糖降解涉及糖苷酶,包括岩藻糖苷酶。“分泌状态”由上皮细胞中的FUT 2活性定义,其形成H抗原并允许随后合成和分泌A、B和刘易斯B抗原。在初步数据中,我们发现,哮喘患者频繁加重比非急性加重更可能是分泌型,分泌型更频繁地报告感冒引起哮喘,稳定型哮喘患者的痰液具有异常高的岩藻糖苷酶活性。这表明气道聚糖受到2种竞争性同源平衡影响,a)合成聚糖的细胞内糖基转移酶的多样性和活性,以及B)在气道腔中翻转和重塑聚糖的糖基化酶的多样性和活性。我们假设分泌物阳性的哮喘受试者对病毒诱导的哮喘急性发作易感,并且分泌物中的糖苷酶活性异常改变聚糖涂层并促进病毒诱导的急性发作。在目的1中,我们提出了一个病例对照研究,以比较分泌状态的住院哮喘患者和门诊哮喘无加重史。本研究也将建立呼吸道上皮细胞分泌状态与FUT基因及组织血型抗原表达之间的关系。在目标2和3中,我们将确定鼻病毒与气道粘蛋白或气道上皮细胞的结合是否受分泌状态或岩藻糖苷酶活性的影响。在目的4中,我们将确定Th 2细胞因子是否通过改变上皮细胞糖基转移酶或糖基化酶的表达来影响上皮细胞对鼻病毒感染的易感性。 这些是对病毒诱导的哮喘急性发作机制的新的调查路线,并可能促进新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John V Fahy其他文献

Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts
开发哮喘保健负担评分作为 SARP III 和 U-BIOPRED 中严重程度的衡量指标和缓解预测因子:来自两个主要纵向哮喘队列的结果
  • DOI:
    10.1016/s2213-2600(24)00250-9
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    32.800
  • 作者:
    Joe G Zein;Nazanin Zounemat-Kermani;Ian M Adcock;Bo Hu;Amy Attaway;Mario Castro;Sven-Erik Dahlén;Loren C Denlinger;Serpil C Erzurum;John V Fahy;Benjamin Gaston;Annette T Hastie;Elliot Israel;Nizar N Jarjour;Bruce D Levy;David T Mauger;Wendy Moore;Michael C Peters;Kaharu Sumino;Elizabeth Townsend;Eugene R Bleecker
  • 通讯作者:
    Eugene R Bleecker

John V Fahy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John V Fahy', 18)}}的其他基金

Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology
评估代谢功能障碍对哮喘病理学和生理学的影响
  • 批准号:
    10688260
  • 财政年份:
    2022
  • 资助金额:
    $ 49.23万
  • 项目类别:
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology
评估代谢功能障碍对哮喘病理学和生理学的影响
  • 批准号:
    10503780
  • 财政年份:
    2022
  • 资助金额:
    $ 49.23万
  • 项目类别:
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
严重哮喘方案中的序贯、多重分配、随机试验 (SMART-SA)
  • 批准号:
    10454345
  • 财政年份:
    2017
  • 资助金额:
    $ 49.23万
  • 项目类别:
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
严重哮喘方案中的序贯、多重分配、随机试验 (SMART-SA)
  • 批准号:
    10221035
  • 财政年份:
    2017
  • 资助金额:
    $ 49.23万
  • 项目类别:
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
严重哮喘方案中的序贯、多重分配、随机试验 (SMART-SA)
  • 批准号:
    9751962
  • 财政年份:
    2017
  • 资助金额:
    $ 49.23万
  • 项目类别:
Carbohydrate-based Therapy for Lung Disease
以碳水化合物为基础的肺部疾病治疗
  • 批准号:
    9766888
  • 财政年份:
    2016
  • 资助金额:
    $ 49.23万
  • 项目类别:
A thiol-saccharide therapy to treat COVID-19
治疗 COVID-19 的硫醇糖疗法
  • 批准号:
    10226074
  • 财政年份:
    2016
  • 资助金额:
    $ 49.23万
  • 项目类别:
Carbohydrate-based Therapy for Lung Disease
以碳水化合物为基础的肺部疾病治疗
  • 批准号:
    10225939
  • 财政年份:
    2016
  • 资助金额:
    $ 49.23万
  • 项目类别:
Carbohydrate-based Therapy for Lung Disease
以碳水化合物为基础的肺部疾病治疗
  • 批准号:
    9147792
  • 财政年份:
    2016
  • 资助金额:
    $ 49.23万
  • 项目类别:
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma
哮喘自我维持型 2 型气道微环境中的上皮细胞重编程和粘液凝胶病理学
  • 批准号:
    10226878
  • 财政年份:
    2012
  • 资助金额:
    $ 49.23万
  • 项目类别:

相似国自然基金

湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
  • 批准号:
    51976048
  • 批准年份:
    2019
  • 资助金额:
    61.0 万元
  • 项目类别:
    面上项目

相似海外基金

COMPAS: co integration of microelectronics and photonics for air and water sensors
COMPAS:微电子学和光子学的共同集成,用于空气和水传感器
  • 批准号:
    10108154
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    EU-Funded
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Standard Grant
SBIR Phase I: High-Efficiency Liquid Desiccant Regenerator for Desiccant Enhanced Evaporative Air Conditioning
SBIR 第一阶段:用于干燥剂增强蒸发空调的高效液体干燥剂再生器
  • 批准号:
    2335500
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Standard Grant
Catalyzing Sustainable Air Travel: Unveiling Consumer Willingness to Pay for Sustainable Aviation Fuel through Information Treatment in Choice Experiment and Cross-Country Analysis
促进可持续航空旅行:通过选择实验和跨国分析中的信息处理揭示消费者支付可持续航空燃油的意愿
  • 批准号:
    24K16365
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Phenotypic and lineage diversification after key innovation(s): multiple evolutionary pathways to air-breathing in labyrinth fishes and their allies
合作研究:关键创新后的表型和谱系多样化:迷宫鱼及其盟友呼吸空气的多种进化途径
  • 批准号:
    2333683
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Continuing Grant
Collaborative Research: Phenotypic and lineage diversification after key innovation(s): multiple evolutionary pathways to air-breathing in labyrinth fishes and their allies
合作研究:关键创新后的表型和谱系多样化:迷宫鱼及其盟友呼吸空气的多种进化途径
  • 批准号:
    2333684
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Continuing Grant
CRII: CSR: Towards an Edge-enabled Software-Defined Vehicle Framework for Dynamic Over-the-Air Updates
CRII:CSR:迈向支持边缘的软件定义车辆框架,用于动态无线更新
  • 批准号:
    2348151
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Standard Grant
Smoldering coarse woody debris and air quality
阴燃粗木质碎片和空气质量
  • 批准号:
    IM240100016
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Mid-Career Industry Fellowships
Simulating Urban Air Pollution In The Lab
在实验室模拟城市空气污染
  • 批准号:
    MR/Y020014/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Fellowship
Development of a low-pressure loss air purification device using rotating porous media and a proposal for its use in ventilation systems
使用旋转多孔介质的低压损失空气净化装置的开发及其在通风系统中的使用建议
  • 批准号:
    24K17404
  • 财政年份:
    2024
  • 资助金额:
    $ 49.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了